Selina directs and edits the long-form analytical articles and infographics at BioCentury, a publication serving a worldwide audience in the biopharma, investment and public policy communities. Selina covers scientific, corporate and strategic content across the biomedical ecosystem and has domain expertise across a wide range of topics relevant to drug developers. Her first love is neurology. She has a deep understanding of neurodegenerative disorders, particularly Alzheimer’s disease, as well as conditions affecting ion channels. Selina joined BioCentury in 2014 after earning a Ph.D. in Neuroscience and conducting postdoctoral research at the University of California San Francisco. Her experiments investigated the role of synaptic plasticity in shaping the development of brain circuits. She holds a B.S. in Neurobiology and Behavior from the University of Washington.
Millions of people around the world are impacted by neurodegenerative diseases— the two most common…
The Business of Innovation: Evolving Models for Life Science Startups to Drive Efficiency and Maximize Value
Since their inception, biotech incubators and accelerators have matured in the resources offered to…